Benzinga·Mar 2·Vandana SinghRallybio Surges 29% on $505M Merger with Candid TherapeuticsRallybio soars as merger with $505M-backed Candid Therapeutics creates combined biotech with $700M cash runway through 2030. RLYBbiotechclinical trials
The Motley Fool·Mar 1·Keith NoonanQuantum Computing Momentum: Rigetti Surges on Sector Optimism Ahead of Q1 ReportRigetti Computing stock surged 9.4% this week on quantum sector momentum from IonQ's strong Q4 results, ahead of its March 4 earnings report. IONQIONQ.WSRGTIRGTIWquantum computingmarket sentiment
The Motley Fool·Feb 25·Josh Kohn-LindquistCircle Internet Group Rallies 35% on Strong Q4 Results and Crypto DemandCircle Internet Group surged 35% after reporting strong Q4 results with 77% revenue growth and 72% USDC stablecoin circulation increase, boosting crypto infrastructure investor confidence. CRCLCOINcryptocurrencyearnings beat
The Motley Fool·Feb 25·Jonathan PoncianoGreat Point Partners Doubles Down on Apogee Therapeutics With $28M PositionGreat Point Partners expands Apogee Therapeutics stake to $28.23M, now its largest holding. Stock doubled in value; Phase 2 atopic dermatitis data expected mid-2026. APGEbiotechclinical trials
The Motley Fool·Feb 25·Jeremy BowmanAxon Enterprise Vaults on Earnings Beat, Eyes Ambitious $6B Revenue TargetAxon Enterprise stock surged 17.46% after beating earnings expectations. The law enforcement tech firm targets $6 billion revenue by 2028, signaling strong growth ahead. AXONrevenue beatQ4 earnings
The Motley Fool·Feb 25·Rich SmithQuantum Computing Inc. Shares Climb 9% Amid Sector VolatilityQuantum Computing Inc. shares rose 9% without clear catalyst amid sector volatility. The stock's extreme valuation multiples reflect speculative investor interest in early-stage quantum technology. QUBTRAAQRAAQURAAQWSPAC mergervaluation
The Motley Fool·Feb 25·Eric VolkmanHycroft Mining Surges on Sprott's Expanded Stake and Resource UpgradeHycroft Mining surged 11% after Eric Sprott increased his stake to 44% and the company upgraded mineral resources by 55%, signaling confidence despite no current revenue. HYMCprecious metalsstock surge
The Motley Fool·Feb 22·Jonathan PoncianoPerceptive Advisors Doubles Down on Praxis, Stock Rallies 320%Perceptive Advisors doubles investment in Praxis Precision Medicines to $588M, now largest holding. Stock surges 320% amid FDA submissions and strong cash position. PRAXFDA approvalinstitutional investment
The Motley Fool·Feb 22·Jonathan PoncianoPerceptive Advisors Doubles Down on Celcuity as Stock Ascends 700% YoYPerceptive Advisors doubled its Celcuity stake to 5.62% of AUM, making it the fund's second-largest holding. Stock surged 700% YoY ahead of expected FDA approval for lead drug Gedatolisib. CELCFDA approvalbiotech
The Motley Fool·Feb 20·Eric VolkmanJAKKS Pacific Shares Surge on Stronger-Than-Expected Q4 ResultsJAKKS Pacific stock surged 24% after beating Q4 earnings expectations with $127M revenue and minimal losses. Tariff relief speculation boosted sentiment, though costume sales declined 28%. JAKKearnings beatQ4 2025 results
The Motley Fool·Feb 20·Scott LevineForum Energy Technologies Beats Estimates on Strong 2026 OutlookForum Energy Technologies beat Q4 earnings estimates and raised 2026 outlook, projecting 6% revenue growth and 16% EBITDA increase. Stock jumped 6.84%. FETQ4 2025 earnings2026 guidance
The Motley Fool·Feb 20·Jonathan PoncianoSeldon Capital Exits Majority Position in ACM Research Amid Strong Stock RallySeldon Capital exits majority stake in ACM Research after selling 183,242 shares for $6.83M. Move comes as semiconductor equipment maker's stock surges 170.7% over past year. ACMRrevenue guidancestock surge
Benzinga·Feb 19·Erica KollmannKnorex Stock Surges on AI-Powered Advertising API LaunchKnorex stock surged 170% after launching an AI-powered advertising API supporting Meta, Google, LinkedIn, and TikTok platforms. Trading volume spiked dramatically amid investor enthusiasm for automation-focused ad tech. GOOGGOOGLKNRXagentic AIad-tech
The Motley Fool·Feb 18·Josh Kohn-LindquistImmunityBio Gains 41% Following European Approval of Bladder Cancer TherapyImmunityBio shares surged 41% after Europe approved its bladder cancer therapy ANKTIVA, enabling commercialization across 30+ nations and opening significant revenue opportunities. IBRXIOVAKRYSbiotechbladder cancer
The Motley Fool·Feb 18·James BrumleyHycroft Mining Shares Rally on Expanded Nevada Resource AssessmentHycroft Mining shares surged 25.9% after an independent assessment revealed 55% more gold and silver reserves in Nevada, with projected resources exceeding $50 billion. HYMCgold miningmineral resources
Benzinga·Feb 18·Vandana SinghSensei Biotherapeutics Surges on Faeth Acquisition and $200M InvestmentSensei Biotherapeutics stock surged 230% after acquiring Faeth Therapeutics and securing $200M investment, expanding its oncology pipeline with PIKTOR therapy. SNSEacquisitionbiotech
The Motley Fool·Feb 18·John RosevearMister Car Wash to Go Private in $7-Per-Share Leonard Green DealMister Car Wash going private in $7-per-share Leonard Green deal, representing 29% premium. Stock surged 16.4% on announcement. MCWacquisitionprivate equity
Benzinga·Feb 18·Lekha GuptaAuddia Shares Surge on Thramann Holdings Merger AgreementAuddia stock surges 70% on merger deal with Thramann Holdings. Combined entity will rebrand as McCarthy Finney, closing in Q2 2026. AUUDAUUDWpremarket tradingstock surge
Benzinga·Feb 18·Mohd HaiderAuddia Stock Rallies on Merger Agreement with Thramann HoldingsAuddia surges on merger agreement with Thramann Holdings, with existing shareholders retaining ~20% ownership. Stock rallied 24% Tuesday but remains near 52-week lows. AUUDAUUDWSEC filingstock surge
Benzinga·Feb 18·Mohd HaiderUrban-Gro Shares Surge on Flash Sports Merger CompletionUrban-Gro shares surge 77.71% after completing Flash Sports merger, regaining Nasdaq compliance. Stock had declined 83% prior year amid underperformance concerns. UGROmergerafter-hours trading